Want to join the conversation?
$GPRO 2Q15 Q&A: Joseph from Barclays asked on feedback on HERO4 Session sales. Tony answered yes, we're getting initial feedback on Session. One of the things we are seeing is kind of nice to get a small data set and we do see it as being relatively additive to premium products.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.